Methods of using ryanodine antagonists in treating neural injury
AssigneeAllergan, Inc.
InventorsCun-Jian Dong, William A. Hare
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of providing neuroprotection to a mammal comprising administering to said mammal suffering from or at risk of suffering a noxious action on its nerve cells an effective amount of a ryanodine antagonist, e.g. dantrolene, to inhibit or prevent nerve cell injury or death.
Claims6
A method of providing neural protection in a human patient suffering from age-related macular degeneration, the method comprising administering dantrolene to said patient.
A method of providing neural protection in a human patient suffering from age-related macular degeneration, the method comprising the intravitreal injection of dantrolene to said patient.
A method of providing neural protection in a human patient suffering from age-related macular degeneration, the method comprising the topical administration to the eye in an ophthalmic solution of dantrolene to said patient.
Dependencies are inferred from the claim text.